Literature DB >> 10834425

Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance.

H Larsson1, B Ahrén.   

Abstract

OBJECTIVE: To characterize in detail the association between insulin sensitivity and islet function in relation to glucose tolerance in nondiabetic subjects. RESEARCH DESIGN AND METHODS: The study included 108 postmenopausal women, aged 57-59 years, with normal glucose tolerance (NGT) or impaired glucose tolerance (IGT) and measured glucose tolerance (World Health Organization, 75 g glucose), insulin sensitivity (euglycemic-hyperinsulinemic clamp), and islet function (the 2-5 min insulin responses [AIR] and glucagon [AGR] responses to 5 g intravenous arginine at fasting, 14 and >25 mmol/l glucose levels). The product of insulin sensitivity and secretion was calculated (disposition index [DI]) and used to study the relationship between the two parameters.
RESULTS: Insulin sensitivity and insulin secretion were highly inversely correlated in a hyperbolic manner (r > 0.64, P < 0.001) in women with NGT (n = 71). Women with IGT (n = 37) had reduced insulin sensitivity compared with women with NGT (P = 0.011). The AIRs were not appropriately increased in relation to the reduced insulin sensitivity in the IGT women, demonstrated as reduced DI in IGT compared with NGT (P < 0.001). Further, women with IGT had an increased AGR (P < 0.001) and a reduced glucose inhibition of glucagon secretion (slopeAGR, P = 0.014) compared with women with NGT. In a multivariate regression model including all of the 108 women, 2-h glucose was independently determined by the DI, the AGR, and the slopeAGR (r = 0.63, P < 0.001).
CONCLUSIONS: We have shown that both the individual ability to adapt insulin secretion to the ambient insulin sensitivity and the level of glucagon secretion are important parameters for maintenance of NGT. Therefore, islet dysfunction in IGT involves low insulin and high glucagon secretion, which present potential targets for correcting impaired glycemia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10834425     DOI: 10.2337/diacare.23.5.650

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  22 in total

1.  Glucagon secretion in relation to insulin sensitivity in healthy subjects.

Authors:  B Ahrén
Journal:  Diabetologia       Date:  2005-12-17       Impact factor: 10.122

Review 2.  Alpha cell function in health and disease: influence of glucagon-like peptide-1.

Authors:  B E Dunning; J E Foley; B Ahrén
Journal:  Diabetologia       Date:  2005-08-13       Impact factor: 10.122

3.  Obesity dysregulates fasting-induced changes in glucagon secretion.

Authors:  Jennifer H Stern; Gordon I Smith; Shiuwei Chen; Roger H Unger; Samuel Klein; Philipp E Scherer
Journal:  J Endocrinol       Date:  2019-11       Impact factor: 4.286

4.  Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia.

Authors:  S L Conarello; G Jiang; J Mu; Z Li; J Woods; E Zycband; J Ronan; F Liu; R Sinha Roy; L Zhu; M J Charron; B B Zhang
Journal:  Diabetologia       Date:  2006-11-28       Impact factor: 10.122

5.  Evidence that autonomic mechanisms contribute to the adaptive increase in insulin secretion during dexamethasone-induced insulin resistance in humans.

Authors:  B Ahrén
Journal:  Diabetologia       Date:  2008-04-24       Impact factor: 10.122

6.  Neuronostatin acts via GPR107 to increase cAMP-independent PKA phosphorylation and proglucagon mRNA accumulation in pancreatic α-cells.

Authors:  Mollisa M Elrick; Willis K Samson; John A Corbett; Alison S Salvatori; Lauren M Stein; Grant R Kolar; Aaron Naatz; Gina L C Yosten
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-11-11       Impact factor: 3.619

7.  Relationship between insulin sensitivity and insulin secretion rate: not necessarily hyperbolic.

Authors:  S H Kim; A Silvers; J Viren; G M Reaven
Journal:  Diabet Med       Date:  2016-01-10       Impact factor: 4.359

8.  Beta- and alpha-cell dysfunction in subjects developing impaired glucose tolerance: outcome of a 12-year prospective study in postmenopausal Caucasian women.

Authors:  B Ahrén
Journal:  Diabetes       Date:  2008-12-18       Impact factor: 9.461

9.  Pancreatic alpha-cell mass across adult human lifespan.

Authors:  Abu Saleh Md Moin; Megan Cory; Tatyana Gurlo; Yoshifumi Saisho; Robert A Rizza; Peter C Butler; Alexandra E Butler
Journal:  Eur J Endocrinol       Date:  2020-02       Impact factor: 6.664

10.  Association of fasting glucagon and proinsulin concentrations with insulin resistance.

Authors:  E Ferrannini; E Muscelli; A Natali; R Gabriel; A Mitrakou; A Flyvbjerg; A Golay; K Hojlund
Journal:  Diabetologia       Date:  2007-09-11       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.